Profile
John A. Geddes is Vice President-Corporate Development at Cardiol Therapeutics, Inc. since 2022.
Formerly, Mr. Geddes was Director-Business Development at Luminex Corp.
from 2010 to 2022, Associate Director-Business Development at Novo Nordisk Canada, Inc. from 2008 to 2010, and VP-Business Development & Marketing at Vasogen, Inc. from 2000 to 2008.
Education includes an MBA from Richard Ivey School of Business and an undergraduate degree from Queen's University.
John Geddes active positions
| Companies | Position | Start |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Corporate Officer/Principal | 2021-12-31 |
Former positions of John Geddes
| Companies | Position | End |
|---|---|---|
| LUMINEX CORPORATION | Corporate Officer/Principal | 2021-12-31 |
Novo Nordisk Canada, Inc.
Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 2009-12-31 |
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Corporate Officer/Principal | 2008-01-09 |
Training of John Geddes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
Luminex Corp.
Luminex Corp. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops, manufactures and markets biological testing technologies | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk Canada, Inc.
Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiol Therapeutics, Inc.
Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- John Geddes
















